Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

BACKGROUND: We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended dose for the phase II study of the combination therapy in advanced breast cancer (ABC) patients pre-treated with anthracycline and taxane. Our...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Iwasa, Tsutomu, Tsurutani, Junji, Watanabe, Satomi, Kato, Ryoji, Mizuno, Yutaka, Kojima, Yasuyuki, Takashima, Tsutomu, Matsunami, Nobuki, Morimoto, Takashi, Yamamura, Jun, Ohtani, Shoichiro, Tanabe, Yuko, Yoshinami, Tetsuhiro, Takano, Toshimi, Komoike, Yoshifumi, Nakagawa, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796350/
https://ncbi.nlm.nih.gov/pubmed/31619197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6200-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados